Company Filing History:
Years Active: 2008
Title: The Innovations of Stephen Matthew Berberich
Introduction
Stephen Matthew Berberich is an accomplished inventor based in Alexandria, OH (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds that can inhibit inflammatory responses in higher mammals.
Latest Patents
Berberich holds a patent for "Tri-substituted ureas as cytokine inhibitors." This invention relates to 1,1,3-tri-substituted ureas that inhibit the extracellular release of inflammatory cytokines, which are responsible for various human and higher mammalian disease states. The patent also covers compositions that include these ureas and methods for controlling the enzymes that contribute to these disease states. He has 1 patent to his name.
Career Highlights
Stephen Berberich is currently employed at The Procter & Gamble Company, where he continues to innovate and develop new solutions in the field of health and wellness. His work focuses on creating effective treatments that can alleviate inflammatory conditions.
Collaborations
Throughout his career, Berberich has collaborated with notable colleagues, including Todd Andrew Brugel and Jennifer Anne Townes. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Stephen Matthew Berberich is a notable inventor whose work in cytokine inhibition has the potential to impact the treatment of inflammatory diseases. His contributions to biotechnology exemplify the importance of innovation in improving health outcomes.